What is CEN Biotech, Inc. (CENBF) stock price today?

CEN Biotech, Inc. (CENBF) is currently trading at $0.00.

What is CENBF P/E ratio?

CEN Biotech, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is CENBF return on equity (ROE)?

CEN Biotech, Inc.'s return on equity (ROE) is 950.00%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is CEN Biotech, Inc.'s market cap?

CEN Biotech, Inc. has a market capitalization of $6526.

OTC · Drug Manufacturers - Specialty & Generic

CEN Biotech, Inc. (CENBF) Stock

$0.00 OTC: CENBF Healthcare

CEN Biotech, Inc. specializes in the creation, production, and ongoing development of both LED lighting technology and goods made from hemp.

Valuation

Metric	Value
Price	$0.00
Market Cap	$6526
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.01
EPS (TTM)	$-0.45
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	950.00%
ROA	-237.50%
ROCE	59.82%
Gross Margin	-1900.00%
Operating Margin	-1900.00%
Net Margin	-1900.00%
Debt/Equity	-1.00
Current Ratio	0.03

Annual Financials (USD)

Metric	2017	2018	2019	2020	2021
Revenue	$0	—	—	$0	$1.0M
Operating Profit	$-12.0M	$-4.0M	$-3.0M	$-3.0M	$-19.0M
Net Profit	$-14.0M	$-8.0M	$-6.0M	$14.0M	$-19.0M
EPS	$-0.56	$-0.30	$-0.21	$0.45	$-0.45
Op Margin	—	—	—	—	-3037.0%

Balance Sheet (USD)

Metric	2017	2018	2019	2020	2021
Total Assets	$9.0M	$7.0M	$7.0M	$6.0M	$8.0M
Total Liabilities	$28.0M	$29.0M	$33.0M	$16.0M	$10.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$10.0M	$10.0M	$10.0M	$1.0M	$2.0M

Cash Flow (USD)

Metric	2017	2018	2019	2020	2021
Operating Cash Flow	$-2.0M	$-2.0M	$-1.0M	$0	$0
Investing Cash Flow	$-1.0M	$0	$0	$0	$0
Financing Cash Flow	$3.0M	$2.0M	$1.0M	$0	$1.0M
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$-2.0M	$-2.0M	$-1.0M	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-6.66
FCF Yield	-7125.91%
Quick Ratio	0.03
Interest Coverage	-5.00
Return 1Y	0.00%
Return 3Y	-99.36%
Return 5Y	-99.98%

Ownership

Insiders Held0.00%

Institutions Held0.00%

Institutions Float Held0.00%

Institutional Holder	Shares	Report Date
MassMutual Private Wealth & Trust, FSB	1	2026-06-30

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BLMSBloomios, Inc.	$0.00	—	—	$19341	0.00%
DNAGDNAPrint Genomics, Inc.	$0.00	—	—	$12892	0.00%
MJNEMJ Holdings, Inc.	$0.00	—	0.00	$11654	0.00%
SAGDSouth American Gold Corp.	$0.00	—	-0.50	$67735	0.00%
SESISES Solar Inc.	$0.00	—	-0.50	$7308	0.00%

About CEN Biotech, Inc.

CEN Biotech, Inc. specializes in the creation, production, and ongoing development of both LED lighting technology and goods made from hemp. The company's future plans include cultivating hemp for use across various sectors, including industrial, medical, and food applications. Furthermore, it provides services in the areas of digital marketing and website development. The firm was founded in 2013 and has its headquarters in Windsor, Canada.

CEN Biotech, Inc. (CENBF) stock trades at $0.00 with a market capitalization of $6526. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.01. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, CEN Biotech, Inc. generates a return on equity (ROE) of 950.00% — well above the market average, a sign of a high-quality business, return on capital employed of 59.82%, an operating margin of -1900.00%, a net profit margin of -1900.00%.

Official website: www.cenbiotechinc.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides